4//SEC Filing
Cunningham Emmett 4
Accession 0000899243-21-024499
CIK 0001563577other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:36 PM ET
Size
6.4 KB
Accession
0000899243-21-024499
Insider Transaction Report
Form 4
Cunningham Emmett
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16+9,888→ 0 totalExercise: $8.90Exp: 2031-06-15→ Common Stock (9,888 underlying)
Footnotes (2)
- [F1]This option shall vest and become exercisable on the earlier of June 16, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.
- [F2]The Reporting Person disclaims beneficial ownership of these securities and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose. The Reporting Person is an employee of The Blackstone Group Inc. or one of its affiliates ("Blackstone"). Pursuant to arrangements between the Reporting Person and Blackstone, the Reporting Person is required to transfer to Blackstone any and all compensation received in connection with his directorship for any company Blackstone invests in or advises.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001710382
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 6:36 PM ET
- Size
- 6.4 KB